New incident report
Incident Report Number: 2015-3922
Registrant Reference Number: 2015TH262
Registrant Name (Full Legal Name no abbreviations): Bayer Inc
Address: 2920 Matheson Blvd
City: Mississauga
Prov / State: ON
Country: Canada
Postal Code: L9W 5R6
Domestic Animal
Country: UNITED STATES
Prov / State: UNKNOWN
PMRA Registration No. PMRA Submission No. EPA Registration No. 11556-155
Product Name: Seresto Collar - large dog
Other (specify)
CollarYes
Other Units: collar
Site: Animal / Usage sur un animal domestique
Other
Dog / Chien
German Shepherd
1
Female
5
120
lbs
Skin
>1 mo <= 6 mos / > 1 mois < = 6 mois
>2 hrs <=8 hrs / > 2 h < = 8 h
System
Persisted until death
Yes
Yes
1
Day(s) / Jour(s)
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 02-Jul-2013, a 5 year old, 120 pound, spayed, female, German Shepherd Dog, in good condition with no known concomitant medical conditions, had 1 Seresto Large Dog (Flumethrin-Imidacloprid) collar placed around the neck by the owner.On 02-Jul-2013, approximately 2 hours post application the dog had a dull coat at the application site. On 09-Jul-2013, the dog the dullness had spread over the rest of the hair coat and the dog had dandruff. On 16-Jul-2013, the dog had shedding. The owner removed the collar. The dog continued to have clinical signs. On 22-Jul-2013, the owner placed the collar back on the dog. On approximately 31-Aug-2013, the dog became lethargic and did not want to walk (reluctant to move). On 08-Sep-2013, the dog began vomiting and would not eat. The owner took the dog to the veterinary clinic where they examined her and performed blood work that revealed hemoconcentration (abnormal test result), leukocytosis with granulocytosis (leukocytosis), an elevated blood urea nitrogen, elevated glucose (hyperglycemia), elevated alanine aminotransferase, and mild hypokalemia. The veterinarian also performed radiographs that showed decreased abdominal detail (abnormal radiograph finding) and cardiomegaly (cardiac enlargement). The patient was then taken to the emergencyveterinary clinic. The veterinarian examined the dog, noting a temperature of 104.2 (pyrexia), a heart rate of 180 (tachycardia), poor pulses (vascular disorder NOS), a respiratory rate of 48 (tachypnea), and pale pink mucous membranes. The dog was in lateral recumbency at that point, was minimally responsive, and had a distended abdomen. The veterinarian performed radiographs that showed an enlarged cardiac silhouette (cardiac enlargement) and a foreign body in the stomach (digestive tract stasis). The dog then collapsed and went into cardiac arrest. The veterinarian performed cardiopulmonary resuscitation, administered two doses of atropine sulfate, and two doses of epinephrine, but the dog died. After the cardiopulmonary resuscitation was performed, the veterinarian noted upon ultrasound that the dog had pericardial effusion, likely due to a right atrial hemangiosarcoma. No necropsy was performed
Death
N- Unlikely. Onset time of skin reactions consistent. However, generalized skin reactions are not anticipated with topical product administration. If any, skin reactions would be localized at the application site. Hair change at application site might be coincidental, since reaction is generalized. Other causes must be considered. Onset time of other signs is inconsistent. Reported systemic signs and fatal outcome are neither expected nor in line with pharmacotoxicological product profile and rather due to dogs underlying medical condition. No necropsy performed. However, reported symptoms, corresponding blood results, ultrasound and radiological findings lead to suspected diagnosis of an haemangiosarcoma. In the end, a product relation was deemed to be unlikely